WallStreetZenWallStreetZen

NASDAQ: ECOR
Electrocore Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for ECOR

Based on 1 analyst offering 12 month price targets for Electrocore Inc.
Min Forecast
$2.75+495.24%
Avg Forecast
$2.75+495.24%
Max Forecast
$2.75+495.24%

Should I buy or sell ECOR stock?

Based on 1 analyst offering ratings for Electrocore Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ECOR stock forecasts and price targets.

ECOR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 7%
7
BuyMaintains$2.75+495.24%2022-01-19

1 of 1

Forecast return on equity

Is ECOR forecast to generate an efficient return?
Company
-28.79%
Industry
20.42%
Market
118.57%
ECOR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ECOR forecast to generate an efficient return on assets?
Company
-23.37%
Industry
11.6%
ECOR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ECOR earnings per share forecast

What is ECOR's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$0.30
Avg 2 year Forecast
-$0.24
Avg 3 year Forecast
-$0.14

ECOR revenue forecast

What is ECOR's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$8.6M+21.84%
Avg 2 year Forecast
$14.6M+107.07%
Avg 3 year Forecast
$23.0M+226.28%
ECOR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ECOR revenue growth forecast

How is ECOR forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
47.58%
Industry
4.27%
Market
8.46%
ECOR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ECOR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ECOR vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
ECOR$0.46$2.75+495.24%Buy
GCTK$2.06N/AN/A
MBOT$4.98$20.00+301.61%Strong Buy
POAI$0.38$5.00+1,208.90%Strong Buy
ISR$0.29N/AN/A

Electrocore Stock Forecast FAQ

Is Electrocore Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ECOR) stock is to Buy ECOR stock.

Out of 1 analyst, 0 (0%) are recommending ECOR as a Strong Buy, 1 (100%) are recommending ECOR as a Buy, 0 (0%) are recommending ECOR as a Hold, 0 (0%) are recommending ECOR as a Sell, and 0 (0%) are recommending ECOR as a Strong Sell.

If you're new to stock investing, here's how to buy Electrocore stock.

What is ECOR's earnings growth forecast for 2022-2024?

(NASDAQ: ECOR) Electrocore's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 23.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.42%.

Electrocore's earnings in 2022 is -$19,859,486.On average, 3 Wall Street analysts forecast ECOR's earnings for 2022 to be -$21,336,323, with the lowest ECOR earnings forecast at -$21,336,323, and the highest ECOR earnings forecast at -$20,625,113. On average, 3 Wall Street analysts forecast ECOR's earnings for 2023 to be -$17,069,059, with the lowest ECOR earnings forecast at -$17,780,270, and the highest ECOR earnings forecast at -$16,357,848.

In 2024, ECOR is forecast to generate -$9,956,951 in earnings, with the lowest earnings forecast at -$12,801,794 and the highest earnings forecast at -$6,400,897.

What is ECOR's revenue growth forecast for 2022-2024?

(NASDAQ: ECOR) Electrocore's forecast annual revenue growth rate of 47.58% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 4.27%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.46%.

Electrocore's revenue in 2022 is $7,033,884.On average, 1 Wall Street analysts forecast ECOR's revenue for 2022 to be $609,507,638, with the lowest ECOR revenue forecast at $609,507,638, and the highest ECOR revenue forecast at $609,507,638. On average, 2 Wall Street analysts forecast ECOR's revenue for 2023 to be $1,035,878,501, with the lowest ECOR revenue forecast at $1,035,522,896, and the highest ECOR revenue forecast at $1,036,234,106.

In 2024, ECOR is forecast to generate $1,632,228,740 in revenue, with the lowest revenue forecast at $1,607,336,363 and the highest revenue forecast at $1,657,121,117.

What is ECOR's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: ECOR) forecast ROA is -23.37%, which is lower than the forecast US Medical Instruments & Supplies industry average of 11.6%.

What is ECOR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ECOR price target, the average ECOR price target is $2.75, with the highest ECOR stock price forecast at $2.75 and the lowest ECOR stock price forecast at $2.75.

The Wall Street analyst predicted that Electrocore's share price could reach $2.75 by Jan 19, 2023. The average Electrocore stock price prediction forecasts a potential upside of 495.24% from the current ECOR share price of $0.46.

What is ECOR's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: ECOR) Electrocore's current Earnings Per Share (EPS) is -$0.29. On average, analysts forecast that ECOR's EPS will be -$0.30 for 2022, with the lowest EPS forecast at -$0.30, and the highest EPS forecast at -$0.29. On average, analysts forecast that ECOR's EPS will be -$0.24 for 2023, with the lowest EPS forecast at -$0.25, and the highest EPS forecast at -$0.23. In 2024, ECOR's EPS is forecast to hit -$0.14 (min: -$0.18, max: -$0.09).

What is ECOR's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: ECOR) forecast ROE is -28.79%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.